| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CARDIORES.2004.07.011 |
| P8608 | Fatcat ID | release_nu4zmiv7ibbsdooiip6jwglz6q |
| P698 | PubMed publication ID | 15485693 |
| P5875 | ResearchGate publication ID | 8230414 |
| P50 | author | Keiichi Tamagaki | Q62269095 |
| P2093 | author name string | Hiroaki Matsubara | |
| Kazuo Takeda | |||
| Tetsuro Kusaba | |||
| Tsuguru Hatta | |||
| Noriko Kuwahara | |||
| Susumu Sasaki | |||
| Hidekazu Irie | |||
| Hisako Kameyama | |||
| Hiromichi Narumiya | |||
| P433 | issue | 2 | |
| P304 | page(s) | 331-336 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells | |
| P478 | volume | 64 |
| Q35025432 | Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy |
| Q90655716 | Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy |
| Q47134765 | Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial. |
| Q42246015 | Glucose Oxidase Induces Cellular Senescence in Immortal Renal Cells through ILK by Downregulating Klotho Gene Expression |
| Q35080598 | Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice |
| Q36914887 | Identification of novel small molecules that elevate Klotho expression |
| Q38016065 | Klotho as a potential biomarker and therapy for acute kidney injury |
| Q35628451 | Klotho gene delivery ameliorates renal hypertrophy and fibrosis in streptozotocin-induced diabetic rats by suppressing the Rho-associated coiled-coil kinase signaling pathway |
| Q34320354 | Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca 2+ channel to maintain endothelial integrity |
| Q26783185 | Klotho, stem cells, and aging |
| Q55442487 | Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease. |
| Q28291037 | Klotho: an antiaging protein involved in mineral and vitamin D metabolism |
| Q36796604 | Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling |
| Q35441666 | Molecular basis of Klotho: from gene to function in aging |
| Q36364310 | Plasma klotho and cardiovascular disease in adults |
| Q39003568 | Potential application of klotho in human chronic kidney disease |
| Q36252339 | Promoter methylation confers kidney-specific expression of the Klotho gene |
| Q24597354 | Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice |
| Q51164635 | Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. |
| Q35903098 | Reduction of Oxidative Stress in Chronic Kidney Disease Does Not Increase Circulating α-Klotho Concentrations |
| Q36672616 | Renal and extrarenal actions of Klotho |
| Q37190542 | Secreted klotho and chronic kidney disease |
| Q53597101 | Soluble Klotho and fibroblast growth factor 23 levels in diabetic nephropathy with different stages of albuminuria. |
| Q36580372 | Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice |
| Q38205938 | The importance of klotho in phosphate metabolism and kidney disease |
| Q39515008 | The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB. |
| Q37430318 | Therapeutic perspectives. |
| Q39812781 | αKlotho and Chronic Kidney Disease |
Search more.